40 Participants Needed

Text Messaging Intervention for Perinatal Depression

(PTMI Trial)

KY
KP
Overseen ByKatarzyna Pasciak, BS
Age: < 65
Sex: Female
Trial Phase: Academic
Sponsor: University of Massachusetts, Worcester
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a text messaging program designed to help prevent depression in pregnant individuals. It aims to determine if supportive texts and helpful videos can reduce the risk of major depression during or after pregnancy. Participants will receive either messages with links to mental health strategies or educational texts about pregnancy and health. This trial is ideal for English-speaking pregnant individuals who have experienced depression before, feel they lack social support, and are comfortable using a smartphone for communication. As an unphased trial, it offers a unique opportunity to contribute to innovative mental health support strategies for pregnant individuals.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications.

What prior data suggests that this text messaging intervention is safe for perinatal individuals?

Research has shown that using text messages for mental health support is generally safe and well-received. Studies have found that these programs can effectively reduce depression symptoms without causing harm. For instance, the Mothers and Babies Course demonstrated positive effects on mental health.

Similar text-based programs have reported no serious side effects. They are usually easy to use and accessible, encouraging continued participation. This is especially beneficial for new or expecting parents with busy schedules.

Text messaging programs offer helpful information and support conveniently, making them a safe choice for managing depression during and after pregnancy. It is always advisable to consult a healthcare provider about any new treatment, especially for mental health.12345

Why are researchers excited about this trial?

Researchers are excited about the Text Messaging Intervention for perinatal depression because it offers a novel approach using technology to provide mental health support. Unlike traditional treatments like psychotherapy or medication, this intervention delivers supportive content and therapy-related information through text messages, making it easily accessible for new and expectant mothers. This method not only provides flexibility and convenience but also helps in reaching a broader audience who may face barriers in accessing traditional mental health care. By using video links and text messages focused on Interpersonal Psychotherapy (IPT), it aims to engage users in a familiar and non-intrusive way, potentially enhancing adherence and outcomes.

What evidence suggests that this text messaging intervention is effective for perinatal depression?

Research has shown that text messaging can effectively support mental health, particularly for new and expecting mothers. In this trial, participants in the "Text4Moms" arm will receive text messages with video links that reinforce information relevant to Interpersonal Psychotherapy (IPT), which focuses on improving relationships to boost mental health. One study found that digital tools like text messages helped reduce depression symptoms in pregnant women and new mothers. Another study demonstrated that text message support significantly lowered the risk of postpartum depression, which affects many new mothers. These interventions are effective because they are easy to access and provide timely support and information.12367

Who Is on the Research Team?

KY

Kimberly Yonkers, MD

Principal Investigator

UMass Chan Medical School

Are You a Good Fit for This Trial?

This trial is for English-speaking individuals at least 16 years old who are pregnant and at risk of depression, as indicated by certain screening scores or a history of depression during pregnancy. Participants must be willing to use a smartphone for text messages but not currently in mental health treatment, living in an institution, planning on terminating the pregnancy, or suffering from panic or substance use disorders.

Inclusion Criteria

I am at risk of postpartum depression based on my depression history or survey scores.
English speaking
I am 16 years old or older.
See 2 more

Exclusion Criteria

You have been diagnosed with panic disorder or substance use disorder.
Currently in behavioral health care treatment
Permanently living in an institutional setting
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2 weeks
1 visit (virtual)

Treatment

Participants receive tailored text messages with links to enhanced content and access to a peer chat function

8 weeks
Continuous virtual engagement

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Text Messaging Intervention
Trial Overview The study is testing a text messaging system designed to lower the risk of major depressive episodes in perinatal individuals. It includes tailored texts with links to resources based on Interpersonal Therapy and offers a peer chat feature. The goal is to see if this intervention can help prevent worsening symptoms of depression.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Text4MomsExperimental Treatment1 Intervention
Group II: Educational ControlActive Control1 Intervention

Text Messaging Intervention is already approved in United States, Canada for the following indications:

🇺🇸
Approved in United States as Text Messaging Intervention for:
🇨🇦
Approved in Canada as Text Messaging Intervention for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Massachusetts, Worcester

Lead Sponsor

Trials
372
Recruited
998,000+

Michigan State University

Collaborator

Trials
202
Recruited
687,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Yale University

Collaborator

Trials
1,963
Recruited
3,046,000+

Worcester Polytechnic Institute

Collaborator

Trials
19
Recruited
30,000+

Published Research Related to This Trial

A pilot study involving 120 pregnant women in Uganda showed that a mobile health messaging app significantly improved attendance at antenatal care visits and skilled deliveries, with 100% of women in the social supporter group attending at least 4 visits.
The app was highly accepted and deemed useful by over 90% of participants, indicating that leveraging social support networks through tailored messaging can effectively promote maternity service use in rural settings.
Evaluating the Feasibility, Acceptability, and Preliminary Efficacy of SupportMoms-Uganda, an mHealth-Based Patient-Centered Social Support Intervention to Improve the Use of Maternity Services Among Pregnant Women in Rural Southwestern Uganda: Randomized Controlled Trial.Atukunda, EC., Siedner, MJ., Obua, C., et al.[2023]
A study involving 20 Hispanic adolescents identified key preferences for SMS-based health promotion messages aimed at reducing underage drinking, focusing on aspects like scheduling, frequency, and content.
Teens showed a strong interest in messages that provided knowledge about alcohol, boosted self-efficacy, and offered social support, highlighting the importance of tailoring SMS interventions to the target audience's needs.
Developing an SMS Intervention for the Prevention of Underage Drinking: Results From Focus Groups.Hospital, MM., Wagner, EF., Morris, SL., et al.[2021]
Text4baby is a pioneering free text messaging service in the U.S. designed to provide essential health information to pregnant women and new mothers, successfully enrolling over 320,000 participants from its launch in 2010 to March 2012.
The rapid enrollment and widespread promotion of Text4baby highlight the effectiveness of public-private partnerships in improving maternal and infant health through accessible communication.
Text4baby: development and implementation of a national text messaging health information service.Whittaker, R., Matoff-Stepp, S., Meehan, J., et al.[2021]

Citations

1.samhsa.govsamhsa.gov/
Home | SAMHSA - Substance Abuse and Mental Health ...SAMHSA leads efforts to advance behavioral health across the U.S., offering resources for mental health, substance use, and community well-being.
Integrating SMS Text Messages Into a Preventive Intervention ...Background: The Mothers and Babies (MB) Course is recognized by the US Preventive Services Task Force as an evidence-based preventive ...
Development of a Text Intervention for Perinatal DepressionNarrative This application is aimed at development and preliminary testing of a text messaging intervention that will reduce the risk of a major depressive ...
Effectiveness of digital health interventions for perinatal ...Abstract. Pregnant women and new mothers within 1 year after delivery are at a high risk of depression, yet many do not get the help they ...
The effectiveness of mobile phone text massaging support ...It is estimated that postpartum depression (PPD) occurs in 10–15% of women in the year after childbirth. The highest number of women with PPD has limited ...
A Text Messaging Intervention to Reduce Perinatal ...A text messaging intervention that will reduce the risk of a major depressive episode and worsening depressive symptoms in perinatal individuals.
The effectiveness of telemedicine interventions, delivered ...Telemedicine interventions significantly decrease postpartum depression symptoms. Women with no history of mental disorders are satisfied with postnatal ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security